Loss of ALX4 expression in epithelial cells and adjacent stromal cells in breast cancer

Journal of Clinical Pathology

Volumn 62, Issue 10, 2009, Pages 908-914

  Chang, H ^a   Mohabir, N ^a   Done, S ^a   Hamel, P A ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARISTALESS LIKE 4; CELL MARKER; HOMEODOMAIN PROTEIN; PROTEIN ANTIBODY; PROTEIN P63; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; BREAST EPITHELIUM; BREAST TUMOR; CANCER INVASION; CELL TYPE; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOCHEMISTRY; IMMUNOFLUORESCENCE; INTRADUCTAL CARCINOMA; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; STROMA CELL; TISSUE MICROARRAY;

ANIMALS; BREAST; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; DNA-BINDING PROTEINS; EPITHELIAL CELLS; FEMALE; HOMEODOMAIN PROTEINS; HUMANS; MAMMARY GLANDS, ANIMAL; MICE; MICE, INBRED C57BL; NEOPLASM PROTEINS; SPECIES SPECIFICITY; STROMAL CELLS; TISSUE ARRAY ANALYSIS; TRANSCRIPTION FACTORS;

EID: 70349659973     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jcp.2009.067298     Document Type: Article

References (27)

1. Barcellos-Hoff MH, Medina D. New highlights on stroma-epithelial interactions in breast cancer. Breast Cancer Res 2005;7:33-36 (Pubitemid 40214535)
2. Silberstein GB. Tumour-stromal interactions. Role of the stroma in mammary development. Breast Cancer Res 2001;3:218-223
3. Shekhar MP, Pauley R, Heppner G. Host microenvironment in breast cancer development: extracellular matrix-stromal cell contribution to neoplastic phenotype of epithelial cells in the breast. Breast Cancer Res 2003;5:130-135
4. Bissell MJ, Rizki A, Mian IS. Tissue architecture: the ultimate regulator of breast epithelial function. Curr Opin Cell Biol 2003;15:753-762 (Pubitemid 37487969)
5. Fata JE, Werb Z, Bissell MJ. Regulation of mammary gland branching morphogenesis by the extracellular matrix and its remodeling enzymes. Breast Cancer Res 2004;6:1-11. (Pubitemid 38195555)
6. Hawsawi NM, Ghebeh H, Hendrayani SF, et al. Breast carcinoma-associated fibroblasts and their counterparts display neoplastic-specific changes. Cancer Res 2008;68:2717-2725 (Pubitemid 351556269)
7. Radisky DC, Bissell MJ. Cancer. Respect thy neighbor! Science 2004;303:775-777
8. Van Nguyen A, Pollard JW. Colony stimulating factor-1 is required to recruit macrophages into the mammary gland to facilitate mammary ductal outgrowth. Dev Biol 2002;247:11-25. (Pubitemid 34681162)
9. Gouon-Evans V, Lin EY, Pollard JW. Requirement of macrophages and eosinophils and their cytokines/chemokines for mammary gland development. Breast Cancer Res 2002;4:155-164 (Pubitemid 35012324)
10. Gouon-Evans V, Rothenberg ME, Pollard JW. Postnatal mammary gland development requires macrophages and eosinophils. Development 2000;127:2269-2282 (Pubitemid 30386567)
11. Wyckoff J, Wang W, Lin EY, et al. A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors. Cancer Res 2004;64:7022-7029 (Pubitemid 39331012)
12. Lin EY, Pollard JW. Macrophages: modulators of breast cancer progression. Novartis Found Symp 2004;256:158-68; discussion 168-72, 259-269
13. Studebaker AW, Storci G, Werbeck JL, et al. Fibroblasts isolated from common sites of breast cancer metastasis enhance cancer cell growth rates and invasiveness in an interleukin-6-dependent manner. Cancer Res 2008;68:9087-9095
14. Giulianelli S, Cerliani JP, Lamb CA, et al. Carcinoma-associated fibroblasts activate progesterone receptors and induce hormone independent mammary tumor growth: a role for the FGF-2/FGFR-2 axis. Int J Cancer 2008;123:2518-2531
15. Schor SL, Schor AM. Phenotypic and genetic alterations in mammary stroma: implications for tumour progression. Breast Cancer Res 2001;3:373-379
16. Hu M, Yao J, Carroll DK, et al. Regulation of in situ to invasive breast carcinoma transition. Cancer Cell 2008;13:394-406. (Pubitemid 351609443)
17. Chen H, Sukumar S. Role of homeobox genes in normal mammary gland development and breast tumorigenesis. J Mammary Gland Biol Neoplasia 2003;8:159-175 (Pubitemid 38129939)
18. Lewis MT. Homeobox genes in mammary gland development and neoplasia. Breast Cancer Res 2000;2:158-169 (Pubitemid 32223580)
19. Qu S, Tucker SC, Ehrlich JS, et al. Mutations in mouse Aristaless-like4 cause Strong's luxoid polydactyly. Development 1998;125:2711-2721 (Pubitemid 28396168)
20. Hudson R, Taniguchi-Sidle A, Boras K, et al. Alx-4, a transcriptional activator whose expression is restricted to sites of epithelial-mesenchymal interactions. Dev Dyn 1998;213:159-169 (Pubitemid 28457767)
21. Joshi PA, Chang H, Hamel PA. Loss of Alx4, a stromally-restricted homeodomain protein, impairs mammary epithelial morphogenesis. Dev Biol 2006;297:284-294 (Pubitemid 44313911)
22. Forsthoefel PF. Responses to selection for plus and minus modifiers of some effects of Strong's luxoid gene on the mouse skeleton. Teratology 1968;1:339-351
23. Forsthoefel PF, Fritts ML, Hatzenbeler LJ. The origin and development of alopecia in mice homozygous for strong's luxoid gene. J Morphol 1966;118:565-580
24. Boras K, Hamel PA. Alx4 binding to LEF-1 regulates N-CAM promoter activity. J Biol Chem 2002;277:1120-1127 (Pubitemid 34968859)
25. Watson CJ, Khaled WT. Mammary development in the embryo and adult: a journey of morphogenesis and commitment. Development 2008;135:995-1003.
26. Hens JR, Wysolmerski JJ. Key stages of mammary gland development: molecular mechanisms involved in the formation of the embryonic mammary gland. Breast Cancer Res 2005;7:220-224
27. Robinson GW, Karpf AB, Kratochwil K. Regulation of mammary gland development by tissue interaction. J Mammary Gland Biol Neoplasia 1999;4:9-19.